Ztalmy
Chemical Name | ganaxolone |
Dosage Form | Suspension (oral; 50 mg/mL) |
Drug Class | Modulators |
System | Nervous |
Company | Marinus Pharmaceuticals |
Approval Year | 2022 |
Indication
- For the treatment of seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients 2 years of age and older